n-methylscopolamine has been researched along with Cognition Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birdsall, NJ; Blessed, G; Bonham, JR; Candy, JM; Dick, DJ; Fairbairn, A; Johnson, M; Perry, EK; Perry, RH; Smith, CJ | 1 |
1 other study(ies) available for n-methylscopolamine and Cognition Disorders
| Article | Year |
|---|---|
Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders.
Topics: Acetylcholinesterase; Aging; Choline O-Acetyltransferase; Cognition Disorders; Hippocampus; Humans; N-Methylscopolamine; Parasympatholytics; Parkinson Disease; Pirenzepine; Receptors, Muscarinic; Reference Values; Scopolamine Derivatives | 1988 |